Dunavin N, Dias A, Li M, McGuirk J. Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease? Biomedicines [Internet]. 2017 Jul 1 [cited 2020 Jul 8];5(3). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618297/
Yang G, Fan X, Liu Y, Jie P, Mazhar M, Liu Y, et al. Immunomodulatory mechanisms and therapeutic potential of mesenchymal stem cells. Stem Cell Rev Rep. 2023;19(5):1214–31.
Article PubMed PubMed Central Google Scholar
Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53(1):e12712.
Galleu A, Riffo-Vasquez Y, Trento C, Lomas C, Dolcetti L, Cheung TS et al. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation. Sci Transl Med. 2017;9(416).
Giacomini C, Granéli C, Hicks R, Dazzi F. The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair. Cell Mol Immunol. 2023;20(6):570–82.
Article PubMed PubMed Central CAS Google Scholar
Cheung TS, Galleu A, von Bonin M, Bornhäuser M, Dazzi F. Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity. Haematologica. 2019;104(10):e438–41.
Article PubMed PubMed Central Google Scholar
Pang SHM, D’Rozario J, Mendonca S, Bhuvan T, Payne NL, Zheng D, et al. Mesenchymal stromal cell apoptosis is required for their therapeutic function. Nat Commun. 2021;12(1):6495.
Article PubMed PubMed Central CAS Google Scholar
Weiss ARR, Dahlke MH. Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs. Front Immunol [Internet]. 2019 Jun 4 [cited 2024 Mar 17];10. https://www.frontiersin.org/journals/immunology/articles/https://doi.org/10.3389/fimmu.2019.01191/full
He X, Hong W, Yang J, Lei H, Lu T, He C, et al. Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine. Sig Transduct Target Ther. 2021;6(1):1–14.
Kholodenko IV, Kholodenko RV, Majouga AG, Yarygin KN. Apoptotic MSCs and MSC-Derived apoptotic bodies as New Therapeutic Tools. Curr Issues Mol Biol. 2022;44(11):5153–72.
Article PubMed PubMed Central CAS Google Scholar
Kadri N, Amu S, Iacobaeus E, Boberg E, Le Blanc K. Current perspectives on mesenchymal stromal cell therapy for graft versus host disease. Cell Mol Immunol. 2023;20(6):613–25.
Article PubMed PubMed Central CAS Google Scholar
Ito A, Aoyama T, Yoshizawa M, Nagai M, Tajino J, Yamaguchi S, et al. The effects of short-term hypoxia on human mesenchymal stem cell proliferation, viability and p16INK4A mRNA expression: investigation using a simple hypoxic culture system with a deoxidizing agent. J Stem Cells Regen Med. 2015;11(1):25–31.
Article PubMed PubMed Central Google Scholar
Li H, Ji XQ, Zhang SM, Bi RH. Hypoxia and inflammatory factor preconditioning enhances the immunosuppressive properties of human umbilical cord mesenchymal stem cells. World J Stem Cells. 2023;15(11):999–1016.
Article PubMed PubMed Central Google Scholar
Sarsenova M, Kim Y, Raziyeva K, Kazybay B, Ogay V, Saparov A. Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells. Front Immunol [Internet]. 2022 Sep 23 [cited 2023 Jan 16];13. https://www.frontiersin.org/articles/10.3389/fimmu.2022.1010399/full
Trajkovska I, Georgievski B, Cevreska L, Gacovski A, Hasan T, Nedeska-Minova N. Early and late complications in patients with allogeneic transplantation of hematopoietic stem cell – case report. Open Access Maced J Med Sci. 2017;5(3):340–3.
Article PubMed PubMed Central Google Scholar
Burnham AJ, Daley-Bauer LP, Horwitz EM. Mesenchymal stromal cells in hematopoietic cell transplantation. Blood Adv. 2020;4(22):5877–87.
Article PubMed PubMed Central CAS Google Scholar
Li HW, Sykes M. Emerging concepts in haematopoietic cell transplantation. Nat Rev Immunol. 2012;12(6):403–16.
Article PubMed PubMed Central CAS Google Scholar
Dazzi F, Clay J, Galleu A. Immune Tolerance in Hemopoietic Stem Cell Transplantation. In: Ratcliffe MJH, editor. Encyclopedia of Immunobiology [Internet]. Oxford: Academic Press; 2016 [cited 2021 May 22]. pp. 241–7. https://www.sciencedirect.com/science/article/pii/B9780123742797150143
Choi SW, Reddy P. Current and emerging strategies for the prevention of graft-versus-host disease. Nat Rev Clin Oncol. 2014;11(9):536–47.
Article PubMed PubMed Central CAS Google Scholar
Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol. 2007;7(5):340–52.
Article PubMed CAS Google Scholar
Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012;12(6):443–58.
Article PubMed PubMed Central CAS Google Scholar
Zhou X, Jin N, Wang F, Chen B. Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease. Cancer Cell Int. 2020;20(1):114.
Article PubMed PubMed Central Google Scholar
Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191.
Article PubMed PubMed Central Google Scholar
Gupta S, Rawat S, Arora V, Kottarath SK, Dinda AK, Vaishnav PK, et al. An improvised one-step sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cells. Stem Cell Res Ther. 2018;9(1):180.
Article PubMed PubMed Central CAS Google Scholar
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.
Article PubMed CAS Google Scholar
Mohanty S, Bose S, Jain KG, Bhargava B, Airan B. TGFβ1 contributes to cardiomyogenic-like differentiation of human bone marrow mesenchymal stem cells. Int J Cardiol. 2013;163(1):93–9.
Rawat S, Srivastava P, Prabha P, Gupta S, Kanga U, Mohanty S. A comparative study on immunomodulatory potential of tissue specific hMSCs. Role of HLA-G; 2018.
De la Rosa-Ruiz MDP, Álvarez-Pérez MA, Cortés-Morales VA, Monroy-García A, Mayani H, Fragoso-González G, et al. Mesenchymal Stem/Stromal cells derived from Dental tissues: a comparative in vitro evaluation of their Immunoregulatory Properties against T cells. Cells. 2019;8(12):22.
Petrenko Y, Vackova I, Kekulova K, Chudickova M, Koci Z, Turnovcova K, et al. A comparative analysis of multipotent mesenchymal stromal cells derived from different sources, with a focus on neuroregenerative potential. Sci Rep. 2020;10:4290.
Article PubMed PubMed Central Google Scholar
Mareschi K, Castiglia S, Sanavio F, Rustichelli D, Muraro M, Defedele D, et al. Immunoregulatory effects on T lymphocytes by human mesenchymal stromal cells isolated from bone marrow, amniotic fluid, and placenta. Exp Hematol. 2016;44(2):138–e1501.
Article PubMed CAS Google Scholar
Lee HJ, Kim SN, Jeon MS, Yi T, Song SU. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells. Sci Rep. 2017;7(1):44486.
Article PubMed PubMed Central CAS Google Scholar
Kara EE, Comerford I, Fenix KA, Bastow CR, Gregor CE, McKenzie DR, et al. Tailored Immune responses: Novel Effector helper T cell subsets in protective immunity. PLoS Pathog. 2014;10(2):e1003905.
Article PubMed PubMed Central Google Scholar
Peshkova M, Korneev A, Suleimanov S, Vlasova II, Svistunov A, Kosheleva N, et al. MSCs’ conditioned media cytokine and growth factor profiles and their impact on macrophage polarization. Stem Cell Res Ther. 2023;14(1):142.
Article PubMed PubMed Central CAS Google Scholar
Bhattacharya P, Dhawan UK, Hussain MT, Singh P, Bhagat KK, Singhal A, et al. Efferocytes release extracellular vesicles to resolve inflammation and tissue injury via prosaposin-GPR37 signaling. Cell Rep. 2023;42(7):112808.
Article PubMed CAS Google Scholar
Gupta S, Rawat S, Krishnakumar V, Rao EP, Mohanty S. Hypoxia preconditioning elicit differential response in tissue-specific MSCs via immunomodulation and exosomal secretion. Cell Tissue Res. 2022;
留言 (0)